Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Am J Physiol Endocrinol Metab ; 309(4): E320-33, 2015 Aug 15.
Article in English | MEDLINE | ID: mdl-26081283

ABSTRACT

Feeding is regulated by perception in the hypothalamus, particularly the first-order arcuate nucleus (ARC) neurons, of the body's energy state. However, the cellular device for converting energy states to the activity of critical neurons in ARC is less defined. We here show that Na(+),K(+)-ATPase (NKA) in ARC senses energy states to regulate feeding. Fasting-induced systemic ghrelin rise and glucose lowering reduced ATP-hydrolyzing activity of NKA and its substrate ATP level, respectively, preferentially in ARC. Lowering glucose concentration (LG), which mimics fasting, decreased intracellular NAD(P)H and increased Na(+) concentration in single ARC neurons that subsequently exhibited [Ca(2+)]i responses to LG, showing that they were glucose-inhibited (GI) neurons. Third ventricular injection of the NKA inhibitor ouabain induced c-Fos expression in agouti-related protein (AgRP) neurons in ARC and evoked neuropeptide Y (NPY)-dependent feeding. When injected focally into ARC, ouabain stimulated feeding and mRNA expressions for NPY and AgRP. Ouabain increased [Ca(2+)]i in single NPY/AgRP neurons with greater amplitude than in proopiomelanocortin neurons in ARC. Conversely, the specific NKA activator SSA412 suppressed fasting-induced feeding and LG-induced [Ca(2+)]i increases in ARC GI neurons. NPY/AgRP neurons highly expressed NKAα3, whose knockdown impaired feeding behavior. These results demonstrate that fasting, via ghrelin rise and LG, suppresses NKA enzyme/pump activity in ARC and thereby promotes the activation of GI neurons and NPY/AgRP-dependent feeding. This study identifies ARC NKA as a hypothalamic sensor and converter of metabolic states to key neuronal activity and feeding behaviour, providing a new target to treat hyperphagic obesity and diabetes.


Subject(s)
Arcuate Nucleus of Hypothalamus/metabolism , Energy Metabolism/genetics , Feeding Behavior/physiology , Glucose/pharmacology , Neurons/drug effects , Sodium-Potassium-Exchanging ATPase/physiology , Adenosine Triphosphate/metabolism , Agouti-Related Protein/metabolism , Animals , Behavior, Animal/physiology , Male , Neurons/metabolism , Neuropeptide Y/metabolism , Rats , Rats, Sprague-Dawley , Rats, Transgenic , Sodium-Potassium-Exchanging ATPase/genetics
2.
No Shinkei Geka ; 41(10): 901-6, 2013 Oct.
Article in Japanese | MEDLINE | ID: mdl-24091462

ABSTRACT

We reported a case of cavernous sinus aspergillosis. A 62-year-old man complained of trigeminal neuralgia in the right V1 region. Neurological examination on admission showed ptosis, loss of light reflex and ophthalmoplegia externa in the right side. MRI enhanced with gadolinium demonstrated sphenoid sinusitis and mass lesion in the right cavernous sinus. MRA revealed right internal carotid artery occlusion. An open biopsy using the extradural temporopolar approach was performed. Pus discharge was observed from the cavernous sinus and histological examination showed hypha of Aspergillus. With early voriconazole treatment, the patient had improvement in headache, ptosis and ophthalmoplegia externa. Cavernous sinus aspergillosis is often found after sphenoiditis. It results in invasion to an internal carotid artery and worsens the patient's prognosis by cerebral infarction, so early diagnosis and treatment are important. We should consider aspergillosis as one of the differential diagnoses of a mass in the cavernous sinus. The epidural approach to this lesion was available to obviate aspergillus dissemination into the medullary cavity.


Subject(s)
Aspergillosis/surgery , Cavernous Sinus/surgery , Neurologic Examination , Ophthalmoplegia/surgery , Sphenoid Sinusitis/surgery , Aspergillosis/complications , Aspergillosis/pathology , Cavernous Sinus/pathology , Humans , Male , Middle Aged , Neurologic Examination/methods , Ophthalmoplegia/etiology , Ophthalmoplegia/pathology , Sphenoid Sinusitis/etiology , Sphenoid Sinusitis/pathology , Treatment Outcome
3.
Neurosci Lett ; 499(3): 194-8, 2011 Jul 25.
Article in English | MEDLINE | ID: mdl-21658429

ABSTRACT

AMP-activated protein kinase (AMPK) is an energy sensor that is activated by the increase of intracellular AMP:ATP ratio. AMPK in the hypothalamic arcuate nucleus (ARC) is activated during fasting and the activation of AMPK stimulates food intake. To clarify the pathway underlying AMPK-induced feeding, we monitored the activity of single ARC neurons by measuring cytosolic Ca(2+) concentration ([Ca(2+)](i)) with fura-2 fluorescence imaging. An AMPK activator, AICA-riboside (AICAR), at 200 µM increased [Ca(2+)](i) in 24% of ARC neurons. AMPK and acetyl CoA carboxylase were phosphorylated in the neurons with [Ca(2+)](i) responses to AICAR. AICAR-induced [Ca(2+)](i) increases were inhibited by Ca(2+)-free condition but not by thapsigargin, suggesting that AICAR increases [Ca(2+)](i) through Ca(2+) influx from extracellular space. Among AICAR-responding ARC neurons, 38% were neuropeptide Y (NPY)-immunoreactive neurons while no proopiomelanocortin (POMC)-immunoreactive neuron was observed. Intracerebroventricular administration of AICAR increased food intake, and the AICAR-induced food intake was abolished by the co-administration of NPY Y1 receptor antagonist, 1229U91. These results indicate that the activation of AMPK leads to the activation of ARC NPY neurons through Ca(2+) influx, thereby causing NPY-dependent food intake. These mechanisms could be implicated in the stimulation of food intake by physiological orexigenic substances.


Subject(s)
AMP-Activated Protein Kinases/physiology , Arcuate Nucleus of Hypothalamus/physiology , Eating/physiology , Neurons/physiology , Neuropeptide Y/physiology , AMP-Activated Protein Kinases/metabolism , Acetyl-CoA Carboxylase/metabolism , Acetyl-CoA Carboxylase/physiology , Aminoimidazole Carboxamide/analogs & derivatives , Aminoimidazole Carboxamide/antagonists & inhibitors , Aminoimidazole Carboxamide/pharmacology , Animals , Arcuate Nucleus of Hypothalamus/drug effects , Arcuate Nucleus of Hypothalamus/enzymology , Arcuate Nucleus of Hypothalamus/metabolism , Calcium/metabolism , Eating/drug effects , Male , Neuropeptide Y/metabolism , Peptides, Cyclic/pharmacology , Phosphorylation , Pro-Opiomelanocortin/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Neuropeptide Y/antagonists & inhibitors , Ribonucleotides/antagonists & inhibitors , Ribonucleotides/pharmacology
4.
Aging (Albany NY) ; 2(11): 775-84, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20966530

ABSTRACT

A recently discovered satiety molecule, nesfatin-1, is localized in neurons of the hypothalamus and brain stem and colocalized with stress-related substances, corticotropin-releasing hormone (CRH), oxytocin, proopiomelanocortin, noradrenaline (NA) and 5-hydroxytryptamine (5-HT). Intracerebroventricular (icv) administration of nesfatin-1 produces fear-related behaviors and potentiates stressor-induced increases in plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in rats. These findings suggest a link between nesfatin-1 and stress. In the present study, we aimed to further clarify the neuronal network by which nesfatin-1 could induce stress responses in rats. Restraint stress induced c-Fos expressions in nesfatin-1-immunoreactive neurons in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus, and in the nucleus of solitary tract (NTS), locus coeruleus (LC) and dorsal raphe nucleus (DR) in the brain stem, without altering plasma nesfatin-1 levels. Icv nesfatin-1 induced c-Fos expressions in the PVN, SON, NTS, LC, DR and median raphe nucleus, including PVN-CRH, NTS-NA, LC-NA and DR-5-HT neurons. Nesfatin-1 increased cytosolic Ca2+ concentration in the CRH-immunoreactive neurons isolated from PVN. Icv nesfatin-1 increased plasma ACTH and corticosterone levels. These results indicate that the central nesfatin-1 system is stimulated by stress and activates CRH, NA and 5-HT neurons and hypothalamic-pituitary-adrenal axis, evoking both central and peripheral stress responses.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Hypothalamo-Hypophyseal System/physiology , Nerve Tissue Proteins/pharmacology , Neurons/drug effects , Norepinephrine/metabolism , Pituitary-Adrenal System/physiology , Serotonin/metabolism , Adrenocorticotropic Hormone/blood , Animals , Behavior, Animal/drug effects , Calcium/metabolism , Calcium-Binding Proteins , Corticosterone/blood , DNA-Binding Proteins , Locus Coeruleus/cytology , Locus Coeruleus/metabolism , Male , Nerve Tissue Proteins/blood , Neurons/metabolism , Nucleobindins , Paraventricular Hypothalamic Nucleus/cytology , Paraventricular Hypothalamic Nucleus/metabolism , Raphe Nuclei/cytology , Raphe Nuclei/metabolism , Rats , Restraint, Physical , Solitary Nucleus/cytology , Solitary Nucleus/metabolism , Stress, Physiological , Stress, Psychological , Supraoptic Nucleus/cytology , Supraoptic Nucleus/metabolism , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...